Balko T, Karlowsky J A, Palatnick L P, Zhanel G G, Hoban D J
Department of Medical Microbiology, Health Sciences Centre, Winnipeg, Manitoba, Canada.
Diagn Microbiol Infect Dis. 1999 Jan;33(1):47-58. doi: 10.1016/s0732-8893(98)00117-5.
An inoculum effect is defined as a four-fold or greater increase in MIC with an increase in bacterial inocula. Haemophilus influenzae was tested for an inoculum effect with ampicillin, cefuroxime, and amoxicillin/clavulanate using the standard initial inocula (5 x 10(5) CFU/mL) and a higher initial inocula (1 x 10(7) CFU/mL). An inoculum effect was observed with both beta-lactamase (TEM-1, ROB-1) positive and beta-lactamase negative strains of H. influenzae when MICs were determined based on turbidity. MICs based on viable cell counts however, demonstrated that only beta-lactamase positive strains of H. influenzae produced an inoculum effect. These observations suggest that MICs determined based on turbidity, using high initial inocula, are not reliable when examining the inoculum effect in H. influenzae. The magnitude of the inoculum effect with beta-lactamase positive strains was beta-lactam dependent (ampicillin > amoxicillin/clavulanate > cefuroxime). beta-lactam kill-curves confirmed the aforementioned results. Addition of the beta-lactamase inhibitor clavulanate completely reversed the inoculum effect in beta-lactamase (TEM-1 and ROB-1) positive strains of H. influenzae with all beta-lactams tested. Introduction of the beta-lactamase gene TEM-1 on plasmid vector pLS88 into a beta-lactamase negative strain of H. influenzae (Rd) produced an inoculum effect based on viable cell counts. In conclusion, our results suggest that the beta-lactam inoculum effect demonstrated by H. influenzae is the result of beta-lactamase production and is poorly assessed by turbidity.
接种物效应的定义是随着细菌接种量的增加,最低抑菌浓度(MIC)增加四倍或更多。使用标准初始接种量(5×10⁵CFU/mL)和更高的初始接种量(1×10⁷CFU/mL),对流感嗜血杆菌进行了氨苄西林、头孢呋辛和阿莫西林/克拉维酸的接种物效应测试。当基于浊度测定MIC时,在β-内酰胺酶(TEM-1、ROB-1)阳性和β-内酰胺酶阴性的流感嗜血杆菌菌株中均观察到接种物效应。然而,基于活菌计数的MIC表明,只有β-内酰胺酶阳性的流感嗜血杆菌菌株产生接种物效应。这些观察结果表明,在检测流感嗜血杆菌的接种物效应时,使用高初始接种量基于浊度测定的MIC并不可靠。β-内酰胺酶阳性菌株的接种物效应大小取决于β-内酰胺类药物(氨苄西林>阿莫西林/克拉维酸>头孢呋辛)。β-内酰胺类药物的杀菌曲线证实了上述结果。添加β-内酰胺酶抑制剂克拉维酸完全逆转了所有测试的β-内酰胺类药物在β-内酰胺酶(TEM-1和ROB-1)阳性的流感嗜血杆菌菌株中的接种物效应。将质粒载体pLS88上的β-内酰胺酶基因TEM-1导入β-内酰胺酶阴性的流感嗜血杆菌菌株(Rd),基于活菌计数产生了接种物效应。总之,我们的结果表明,流感嗜血杆菌所表现出的β-内酰胺类接种物效应是β-内酰胺酶产生的结果,并且通过浊度法评估效果不佳。